169 related articles for article (PubMed ID: 33981975)
1. Multiple pathways coordinating reprogramming of endothelial cells into osteoblasts by BMP4.
Yu G; Shen P; Lee YC; Pan J; Song JH; Pan T; Lin SC; Liang X; Wang G; Panaretakis T; Logothetis CJ; Gallick GE; Yu-Lee LY; Lin SH
iScience; 2021 Apr; 24(4):102388. PubMed ID: 33981975
[TBL] [Abstract][Full Text] [Related]
2. Prostate tumor-induced stromal reprogramming generates Tenascin C that promotes prostate cancer metastasis through YAP/TAZ inhibition.
Lee YC; Lin SC; Yu G; Zhu M; Song JH; Rivera K; Pappin DJ; Logothetis CJ; Panaretakis T; Wang G; Yu-Lee LY; Lin SH
Oncogene; 2022 Feb; 41(6):757-769. PubMed ID: 34845375
[TBL] [Abstract][Full Text] [Related]
3. Retinoic Acid Receptor Activation Reduces Metastatic Prostate Cancer Bone Lesions by Blocking the Endothelial-to-Osteoblast Transition.
Yu G; Corn PG; Shen P; Song JH; Lee YC; Lin SC; Pan J; Agarwal SK; Panaretakis T; Pacifici M; Logothetis CJ; Yu-Lee LY; Lin SH
Cancer Res; 2022 Sep; 82(17):3158-3171. PubMed ID: 35802768
[TBL] [Abstract][Full Text] [Related]
4. Endothelial-to-Osteoblast Conversion Generates Osteoblastic Metastasis of Prostate Cancer.
Lin SC; Lee YC; Yu G; Cheng CJ; Zhou X; Chu K; Murshed M; Le NT; Baseler L; Abe JI; Fujiwara K; deCrombrugghe B; Logothetis CJ; Gallick GE; Yu-Lee LY; Maity SN; Lin SH
Dev Cell; 2017 Jun; 41(5):467-480.e3. PubMed ID: 28586644
[TBL] [Abstract][Full Text] [Related]
5. Endothelial-to-osteoblast transition in normal mouse bone development.
Lin SC; Yu G; Lee YC; Song JH; Song X; Zhang J; Panaretakis T; Logothetis CJ; Komatsu Y; Yu-Lee LY; Wang G; Lin SH
iScience; 2023 Feb; 26(2):105994. PubMed ID: 36798441
[TBL] [Abstract][Full Text] [Related]
6. BMP4 promotes prostate tumor growth in bone through osteogenesis.
Lee YC; Cheng CJ; Bilen MA; Lu JF; Satcher RL; Yu-Lee LY; Gallick GE; Maity SN; Lin SH
Cancer Res; 2011 Aug; 71(15):5194-203. PubMed ID: 21670081
[TBL] [Abstract][Full Text] [Related]
7. Osteoblastic Factors in Prostate Cancer Bone Metastasis.
Lin SC; Yu-Lee LY; Lin SH
Curr Osteoporos Rep; 2018 Dec; 16(6):642-647. PubMed ID: 30203251
[TBL] [Abstract][Full Text] [Related]
8. Prostate cancer-induced endothelial-to-osteoblast transition generates an immunosuppressive bone tumor microenvironment.
Yu G; Corn PG; Mak CSL; Liang X; Zhang M; Troncoso P; Song JH; Lin SC; Song X; Liu J; Zhang J; Logothetis CJ; Melancon MP; Panaretakis T; Wang G; Lin SH
bioRxiv; 2023 Dec; ():. PubMed ID: 38076845
[TBL] [Abstract][Full Text] [Related]
9. Notch signaling and ERK activation are important for the osteomimetic properties of prostate cancer bone metastatic cell lines.
Zayzafoon M; Abdulkadir SA; McDonald JM
J Biol Chem; 2004 Jan; 279(5):3662-70. PubMed ID: 14602722
[TBL] [Abstract][Full Text] [Related]
10. Prostate cancer cells induce osteoblast differentiation through a Cbfa1-dependent pathway.
Yang J; Fizazi K; Peleg S; Sikes CR; Raymond AK; Jamal N; Hu M; Olive M; Martinez LA; Wood CG; Logothetis CJ; Karsenty G; Navone NM
Cancer Res; 2001 Jul; 61(14):5652-9. PubMed ID: 11454720
[TBL] [Abstract][Full Text] [Related]
11. Axin2 controls bone remodeling through the beta-catenin-BMP signaling pathway in adult mice.
Yan Y; Tang D; Chen M; Huang J; Xie R; Jonason JH; Tan X; Hou W; Reynolds D; Hsu W; Harris SE; Puzas JE; Awad H; O'Keefe RJ; Boyce BF; Chen D
J Cell Sci; 2009 Oct; 122(Pt 19):3566-78. PubMed ID: 19737815
[TBL] [Abstract][Full Text] [Related]
12. Secretome analysis of an osteogenic prostate tumor identifies complex signaling networks mediating cross-talk of cancer and stromal cells within the tumor microenvironment.
Lee YC; Gajdosik MS; Josic D; Clifton JG; Logothetis C; Yu-Lee LY; Gallick GE; Maity SN; Lin SH
Mol Cell Proteomics; 2015 Mar; 14(3):471-83. PubMed ID: 25527621
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of GSK3β Stimulates BMP Signaling and Decreases SOST Expression Which Results in Enhanced Osteoblast Differentiation.
Schoeman MA; Moester MJ; Oostlander AE; Kaijzel EL; Valstar ER; Nelissen RG; Löwik CW; de Rooij KE
J Cell Biochem; 2015 Dec; 116(12):2938-46. PubMed ID: 26095393
[TBL] [Abstract][Full Text] [Related]
14. Prostate cancer-secreted CCN3 uses the GSK3β and β-catenin pathways to enhance osteogenic factor levels in osteoblasts.
Chen PC; Liu SC; Lin TH; Lin LW; Wu HC; Tai HC; Wang SW; Tang CH
Environ Toxicol; 2021 Mar; 36(3):425-432. PubMed ID: 33107671
[TBL] [Abstract][Full Text] [Related]
15. Prostate cancer cells-osteoblast interaction shifts expression of growth/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts.
Fizazi K; Yang J; Peleg S; Sikes CR; Kreimann EL; Daliani D; Olive M; Raymond KA; Janus TJ; Logothetis CJ; Karsenty G; Navone NM
Clin Cancer Res; 2003 Jul; 9(7):2587-97. PubMed ID: 12855635
[TBL] [Abstract][Full Text] [Related]
16. Low-density lipoprotein receptor-related protein 5 (LRP5) mediates the prostate cancer-induced formation of new bone.
Li ZG; Yang J; Vazquez ES; Rose D; Vakar-Lopez F; Mathew P; Lopez A; Logothetis CJ; Lin SH; Navone NM
Oncogene; 2008 Jan; 27(5):596-603. PubMed ID: 17700537
[TBL] [Abstract][Full Text] [Related]
17. Osteoblast-secreted WISP-1 promotes adherence of prostate cancer cells to bone via the VCAM-1/integrin α4β1 system.
Chang AC; Chen PC; Lin YF; Su CM; Liu JF; Lin TH; Chuang SM; Tang CH
Cancer Lett; 2018 Jul; 426():47-56. PubMed ID: 29627497
[TBL] [Abstract][Full Text] [Related]
18. Functional Notch signaling is required for BMP4-induced inhibition of myogenic differentiation.
Dahlqvist C; Blokzijl A; Chapman G; Falk A; Dannaeus K; Ibâñez CF; Lendahl U
Development; 2003 Dec; 130(24):6089-99. PubMed ID: 14597575
[TBL] [Abstract][Full Text] [Related]
19. AMPK/GSK3β/β-catenin cascade-triggered overexpression of CEMIP promotes migration and invasion in anoikis-resistant prostate cancer cells by enhancing metabolic reprogramming.
Zhang P; Song Y; Sun Y; Li X; Chen L; Yang L; Xing Y
FASEB J; 2018 Jul; 32(7):3924-3935. PubMed ID: 29505302
[TBL] [Abstract][Full Text] [Related]
20. BMP9 prevents induction of osteopontin in JNK-inactivated osteoblasts via Hey1-Id4 interaction.
Kusuyama J; Seong C; Nakamura T; Ohnishi T; Amir MS; Shima K; Semba I; Noguchi K; Matsuguchi T
Int J Biochem Cell Biol; 2019 Nov; 116():105614. PubMed ID: 31550547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
